(6-[4-(aminomethyl)-2,6-dimethylphenoxy]-2-{[4-(aminomethyl)phenyl]amino}-5-bromopyrimidin-4-yl)methanol

This compound is a synthetic small molecule with the IUPAC name (6-[4-(aminomethyl)-2,6-dimethylphenoxy]-2-{[4-(aminomethyl)phenyl]amino}-5-bromopyrimidin-4-yl)methanol. It has been studied as a ligand and inhibitor in structural biology research involving reverse transcriptase enzymes. The molecule contains aminomethyl and dimethyl substitutions on phenoxy and phenyl rings attached to a brominated pyrimidinyl core with a methanol group. Its primary use appears to be as an experimental tool compound for biochemical or structural studies of reverse transcriptase, rather than as an approved pharmaceutical agent[8][2]. There is no evidence it has reached clinical development or approval for any therapeutic indication.